Diversion Control Division, US Department of Justice, Drug Enforcement Administration

ABOUT US > DEA Meetings & Events > Practitioner Diversion Awareness Conference > November 18 & 19, 2018; Nashville, Tennessee

Practitioner Diversion Awareness Conference

November 18 & 19, 2018; Renaissance Nashville Hotel – Nashville, Tennessee

The Drug Enforcement Administration (DEA) held a Practitioner Awareness Conference (PDAC) on November 18 & 19, 2018 in Nashville, Tennessee. This was a one-day conference, repeated on the second day, for the convenience of the practitioner community. The conference was developed and designed to address the growing problem of diversion of pharmaceutical controlled substances throughout the United States. In addition to pharmacy robberies and thefts, pharmaceutical controlled substances are often diverted by way of forged prescriptions, doctor shoppers, or illegitimate prescriptions from rogue practitioners. The objective of this conference was to educate healthcare professionals on ways to address and respond to potential diversion activity.

Over 575 veterinarians, dentists, physician assistants, and nurse practitioners attended. The conference attendees received approximately seven hours of instruction on a variety of topics. The presentations included; The Opioid Epidemic and the Practice of Legitimate Medicine, Drugs of Abuse and Trends, Prescription Drug Monitoring Programs, Prescriptions for Controlled Substances, Methods of Diversion and Effective Controls for Controlled Substances, State Medical Board, Inventories, Records, and Reports, Registration Issues, Disposal, Return of Patient Meds, and Options for Patients, Telemedicine, and Training & Resources.

Selected presentations from the Nashville, Tennessee PDAC are below.

The Opioid Epidemic and the Practice of Legitimate Medicine – James A. Arnold, Section Chief, Liaison Section, Diversion Control Division, DEA

Drugs of Abuse and Trends – Scott A. Brinks, Unit Chief, Liaison Unit, Diversion Control Division, DEA

Prescription Drug Monitoring Programs (PDMPs) – Dr. D. Todd Bess, Director of Controlled Substance Monitoring Database, Tennessee Department of Health

Prescriptions for Controlled Substances – Loren T. Miller, Section Chief, Policy Section, Diversion Control Division, DEA

Methods of Diversion and Effective Controls for Controlled Substances – Scott A. Brinks, Unit Chief, Liaison Unit, Diversion Control Division, DEA

State Medical Board – Dr. David Reagan, Chief Medical Officer, Tennessee Department of Health

Inventories, Records, and Reports – Lynnette M. Wingert, Unit Chief, Policy Unit, Diversion Control Division, DEA

Registration Issues – Loren T. Miller, Section Chief, Policy Section, Diversion Control Division, DEA

Disposal, Return of Patient Meds, and Options for Patients – Kathy L. Federico, Acting Section Chief, Regulatory Drafting Section, Diversion Control Division, DEA

Telemedicine – James A. Arnold, Section Chief, Liaison Section, Diversion Control Division, DEA

Training & Resources – Kathy L. Federico, Acting Section Chief, Regulatory Drafting Section, Diversion Control Division, DEA

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility